Edmonton, Alberta–(Newsfile Corp. – March 17, 2025) – Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under clinical investigation as a first-in-class targeted therapy for the treatment of hematologic cancers. Pacylex has 27 additional potent NTMis …
Read More »
Breaking News
- Getchell Gold Corp Invites Shareholders and Investment Community to visit us at Booth 532 at the VRIC in Vancouver, January 25-26, 2026
- Medaro Mining Grants Stock Options and RSRs and Announces Completion of Assignment Agreement
- Red Metal Resources Closes First Tranche of Financing
- Alma Gold Announces the Retirement of Director Jean-Marc Gagnon
- Advanced Gold Announces Closing of Private Placement
- Duramax Sheds Online Announces Interactive Shed Size Calculator
- Dynasty Gold Expands Mineralization into a New Zone at Thundercloud and Exhibiting at VRIC 2026, Vancouver (January 25-26), Booth 1029
- DelphX Announces Non-Brokered Unit Private Placement
- DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India
- FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar